A phase III trial of ponesimod in patients with severe chronic plaque psoriasis.

Trial Profile

A phase III trial of ponesimod in patients with severe chronic plaque psoriasis.

Planning
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2013

At a glance

  • Drugs Ponesimod (Primary)
  • Indications Plaque psoriasis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 22 Jul 2013 Commencement of this trial is on hold until a second generation S1P modulator has been assessed by the company.
    • 20 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top